Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrun Roeber

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Acta Neuropathologica|July 22, 2019
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagyChristopher P Cali, Maribel Patino, Yee Kit Tai, et al.
Acta Neuropathologica|November 24, 2024
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathiesLuna Slemann, Johannes Gnörich, Selina Hummel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear PalsyKonstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsyMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
Nature Genetics|December 27, 2011
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsRosa Rademakers, Matt Baker, Alexandra M Nicholson, et al.
The Lancet. Neurology|July 16, 2022
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy studyAndreas Charidimou, Gregoire Boulouis, Matthew P Frosch, et al.
Nature Communications|March 16, 2022
Tau deposition patterns are associated with functional connectivity in primary tauopathiesNicolai Franzmeier, Matthias Brendel, Leonie Beyer, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Acta Neuropathologica|July 22, 2019
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagyChristopher P Cali, Maribel Patino, Yee Kit Tai, et al.
Acta Neuropathologica|November 24, 2024
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathiesLuna Slemann, Johannes Gnörich, Selina Hummel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear PalsyKonstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsyMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
Nature Genetics|December 27, 2011
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsRosa Rademakers, Matt Baker, Alexandra M Nicholson, et al.
The Lancet. Neurology|July 16, 2022
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy studyAndreas Charidimou, Gregoire Boulouis, Matthew P Frosch, et al.
Nature Communications|March 16, 2022
Tau deposition patterns are associated with functional connectivity in primary tauopathiesNicolai Franzmeier, Matthias Brendel, Leonie Beyer, et al.
Pageof 8